APAmanda PeBenito

Amanda PeBenito

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Amanda PeBenito has a total of 21 co-authors. Here are the top co-authors by number of shared publications:

  • Augustin Vannier

    Department of Medicine, Section of Hematology and Oncology, University of Chicago, Chicago, Illinois

    1 shared publication
  • Ben Wardwell

    MGH Alcohol Liver Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, United States; Gastrointestinal Unit, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, United States

    1 shared publication
  • Chan Wang

    Department of Population Health, NYU Langone Health, NY, United States

    1 shared publication
  • Dmitriy Kedrin

    MGH Alcohol Liver Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, United States

    1 shared publication
  • Esperance Schaefer

    MGH Alcohol Liver Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, United States; Gastrointestinal Unit, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, United States; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, United States

    1 shared publication
  • Huilin Li

    NYU Langone Health 7 Department of Population Health, New York University School of Medicine New York, New York

    1 shared publication

Latest Publications

  • Serum HMGB1 associates with liver disease and predicts readmission and mortality in patients with alcohol use disorder

    by Augustin G.L. Vannier, Ben Wardwell, Vladislav Fomin, Amanda PeBenito, Nicholas Wolczynski, Samuel Piaker, Dmitriy Kedrin, Raymond T. Chung, Esperance Schaefer, Russell Goodman, et al.


  • Open Access

    Comparative prevalence of Oxalobacter formigenes in three human populations

    by Amanda PeBenito, Lama Nazzal, Chan Wang, Huilin Li, Melanie Jay, Oscar Noya-Alarcon, Monica Contreras, Orlana Lander, Jeff Leach, Maria Gloria Dominguez-Bello, et al.

    There has been increasing interest in the human anaerobic colonic bacterium Oxalobacter formigenes because of its ability to metabolize oxalate, and its potential contribution to protection from calcium oxalate kidney stones. Prior studies examining the prevalence of this organism have focused on subjects in developed countries and on adults. Now using O. formigenes-specific PCR, we have compared the prevalence of these organisms among subjects in two remote areas in which modern medical practices have hardly been present with a USA group of mothers and their infants for the first three years of life. Among the Amerindians of the Yanomami-Sanema and Yekwana ethnic groups in Venezuela and the Hadza in Tanzania, O. formigenes was detected in 60–80% of the adult subjects, higher than found in adults from USA in this and prior studies. In young children, the prevalence was much lower in USA than in either tribal village. These data extend our understanding of the epidemiology of O. formigenes carriage, and are consistent with the hypothesis that the rising incidence of kidney stones is associated with the progressive loss of O. formigenes colonization in populations that have been highly impacted by modern medical practices.